Growth Metrics

Lifevantage (LFVN) EPS (Weighted Average and Diluted) (2016 - 2025)

Lifevantage's EPS (Weighted Average and Diluted) history spans 16 years, with the latest figure at $0.02 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 89.47% year-over-year to $0.02; the TTM value through Dec 2025 reached $0.6, up 7.14%, while the annual FY2025 figure was $0.75, 226.09% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.02 in Q4 2025 per LFVN's latest filing, down from $0.17 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.35 in Q2 2021 to a low of -$0.11 in Q2 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.1, with a median of $0.11 recorded in 2021.
  • Peak YoY movement for EPS (Weighted Average and Diluted): plummeted 900.0% in 2022, then skyrocketed 480.0% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.01 in 2021, then tumbled by 900.0% to -$0.08 in 2022, then soared by 37.5% to -$0.05 in 2023, then soared by 480.0% to $0.19 in 2024, then tumbled by 89.47% to $0.02 in 2025.
  • Per Business Quant, the three most recent readings for LFVN's EPS (Weighted Average and Diluted) are $0.02 (Q4 2025), $0.17 (Q3 2025), and $0.15 (Q2 2025).